Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
China
· Delayed Price · Currency is CNY 25.31
+0.32 (1.28%)
Mar 28, 2025, 3:00 PM CST
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,370 employees as of December 31, 2023. The number of employees increased by 1,971 or 5.13% compared to the previous year.
Employees
40,370
Change (1Y)
1,971
Growth (1Y)
5.13%
Revenue / Employee
1.03M CNY
Profits / Employee
52.36K CNY
Market Cap
61.33B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Jiangsu Hengrui Medicine | 19,611 |
| Shenzhen Mindray Bio-Medical Electronics | 18,044 |
| WuXi AppTec | 39,414 |
| Aier Eye Hospital Group | 36,718 |
| Zhangzhou Pientzehuang Pharmaceutical., | 2,789 |
| Yunnan Baiyao Group Co.,Ltd | 8,834 |
| Shanghai United Imaging Healthcare | 7,440 |
| Sichuan Biokin Pharmaceutical | 2,086 |
Shanghai Fosun Pharmaceutical (Group) News
- 3 days ago - Shanghai Fosun Pharmaceutical reports FY results - Seeking Alpha
- 1 year ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 2 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 3 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 4 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 4 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 4 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha
- 4 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC